Combination of oncolytic adenovirotherap
β
Masayoshi Hioki; Shunsuke Kagawa; Toshiya Fujiwara; Ryo Sakai; Toru Kojima; Yuic
π
Article
π
2008
π
John Wiley and Sons
π
French
β 292 KB
## Abstract Cancer gene therapy and oncolytic virotherapy have been studied extensively. However, their clinical application is hampered by their weak anticancer activity. We previously constructed a replicating adenovirus (OBPβ301, Telomelysin), in which the human telomerase reverse transcriptase